vs
Side-by-side financial comparison of ACORN ENERGY, INC. (ACFN) and Bolt Biotherapeutics, Inc. (BOLT). Click either name above to swap in a different company.
Bolt Biotherapeutics, Inc. is the larger business by last-quarter revenue ($2.5M vs $2.4M, roughly 1.1× ACORN ENERGY, INC.). ACORN ENERGY, INC. runs the higher net margin — 45.2% vs -265.2%, a 310.4% gap on every dollar of revenue. Over the past eight quarters, ACORN ENERGY, INC.'s revenue compounded faster (5.6% CAGR vs -31.2%).
Acorn Energy Inc. is a NASDAQ-listed conglomerate investing in electricity generation and security. It was founded by George Morgenstern in 1984 as Decision Systems, Inc. and was taken public by Laidlaw Securities. The name was later changed to Data Systems and Software Inc. John Moore became CEO in 2006 and changed the name to Acorn Factor and later to Acorn Energy.
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.
ACFN vs BOLT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.4M | $2.5M |
| Net Profit | $1.1M | $-6.6M |
| Gross Margin | 80.1% | — |
| Operating Margin | 11.7% | -283.4% |
| Net Margin | 45.2% | -265.2% |
| Revenue YoY | -32.6% | — |
| Net Profit YoY | -79.5% | 58.4% |
| EPS (diluted) | $0.42 | $-9.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.4M | $2.5M | ||
| Q3 25 | $2.5M | $2.2M | ||
| Q2 25 | $3.5M | $1.8M | ||
| Q1 25 | $3.1M | $1.2M | ||
| Q4 24 | $3.5M | $0 | ||
| Q3 24 | $3.0M | $1.1M | ||
| Q2 24 | $2.3M | $1.3M | ||
| Q1 24 | $2.1M | $5.3M |
| Q4 25 | $1.1M | $-6.6M | ||
| Q3 25 | $252.0K | $-7.1M | ||
| Q2 25 | $720.0K | $-8.6M | ||
| Q1 25 | $464.0K | $-11.0M | ||
| Q4 24 | $5.2M | $-15.9M | ||
| Q3 24 | $725.0K | $-15.2M | ||
| Q2 24 | $271.0K | $-21.2M | ||
| Q1 24 | $65.0K | $-10.8M |
| Q4 25 | 80.1% | — | ||
| Q3 25 | 78.5% | — | ||
| Q2 25 | 74.9% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 72.4% | — | ||
| Q3 24 | 71.7% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 74.6% | — |
| Q4 25 | 11.7% | -283.4% | ||
| Q3 25 | 6.4% | -355.1% | ||
| Q2 25 | 26.9% | -510.5% | ||
| Q1 25 | 19.5% | -991.4% | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | 24.8% | -1441.1% | ||
| Q2 24 | 11.3% | -1772.3% | ||
| Q1 24 | 3.7% | -324.1% |
| Q4 25 | 45.2% | -265.2% | ||
| Q3 25 | 10.2% | -329.4% | ||
| Q2 25 | 20.4% | -474.6% | ||
| Q1 25 | 15.0% | -903.4% | ||
| Q4 24 | 148.3% | — | ||
| Q3 24 | 23.8% | -1330.1% | ||
| Q2 24 | 11.9% | -1662.4% | ||
| Q1 24 | 3.0% | -205.0% |
| Q4 25 | $0.42 | $-9.38 | ||
| Q3 25 | $0.10 | $-3.72 | ||
| Q2 25 | $0.28 | $-4.46 | ||
| Q1 25 | $0.19 | $-0.29 | ||
| Q4 24 | $2.08 | $-13.73 | ||
| Q3 24 | $0.29 | $-7.93 | ||
| Q2 24 | $0.11 | $-11.12 | ||
| Q1 24 | $0.03 | $-0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5M | $27.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.3M | $26.5M |
| Total Assets | $13.3M | $56.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.5M | $27.5M | ||
| Q3 25 | $4.2M | $31.9M | ||
| Q2 25 | $3.3M | $34.8M | ||
| Q1 25 | $2.6M | $38.8M | ||
| Q4 24 | $2.3M | $47.3M | ||
| Q3 24 | $2.2M | $53.8M | ||
| Q2 24 | $1.5M | $73.7M | ||
| Q1 24 | $1.4M | $91.3M |
| Q4 25 | $8.3M | $26.5M | ||
| Q3 25 | $7.2M | $32.1M | ||
| Q2 25 | $6.9M | $38.8M | ||
| Q1 25 | $6.1M | $46.8M | ||
| Q4 24 | $5.5M | $57.2M | ||
| Q3 24 | $288.0K | $72.0M | ||
| Q2 24 | $-451.0K | $85.9M | ||
| Q1 24 | $-733.0K | $104.2M |
| Q4 25 | $13.3M | $56.7M | ||
| Q3 25 | $12.4M | $65.1M | ||
| Q2 25 | $12.5M | $75.5M | ||
| Q1 25 | $11.1M | $85.9M | ||
| Q4 24 | $10.6M | $99.6M | ||
| Q3 24 | $5.4M | $109.3M | ||
| Q2 24 | $4.8M | $124.2M | ||
| Q1 24 | $4.9M | $142.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $295.0K | $-7.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $295.0K | $-7.2M | ||
| Q3 25 | $895.0K | $-9.7M | ||
| Q2 25 | $629.0K | $-9.6M | ||
| Q1 25 | $271.0K | $-13.4M | ||
| Q4 24 | $166.0K | $-14.4M | ||
| Q3 24 | $698.0K | $-14.0M | ||
| Q2 24 | $84.0K | $-16.1M | ||
| Q1 24 | $-43.0K | $-16.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1227.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 0.27× | — | ||
| Q3 25 | 3.55× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.96× | — | ||
| Q2 24 | 0.31× | — | ||
| Q1 24 | -0.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACFN
| PG | $2.2M | 94% |
| Other | $143.0K | 6% |
BOLT
Segment breakdown not available.
